SEC Form 4 · accession 0001735276-18-000048
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Manmeet Singh Soni
Officer — Chief Financial Officer
Period of report
Aug 13, 2018
Accepted (ET)
Aug 14, 2018 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 25, 2017 | J | 2 | $0.00 | A | 2 | I | by Managed Account |
| Common StockF1 | Oct 16, 2017 | J | 11 | $0.00 | A | 13 | I | by Managed Account |
| Common StockF1 | Jan 17, 2018 | J | 6 | $0.00 | A | 19 | I | by Managed Account |
| Common StockF1 | Apr 16, 2018 | J | 28 | $0.00 | A | 47 | I | by Managed Account |
| Common StockF1 | Jul 10, 2018 | J | 36 | $0.00 | A | 83 | I | by Managed Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Stock Option 2017 (right to buy) | $52.61 | Aug 13, 2018 | A | 25,000 | A | Aug 13, 2018 | May 8, 2027 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- F2On May 8, 2017, the reporting person was granted a performance based stock option to purchase shares of ALNY common stock. The shares subject to the option will vest upon the commercial launch of Alnylams first internally developed product, as approved by our compensation committee. Effective August 13, 2018, the compensation committee of the Company determined the performance criterion has been met and the option shares have vested.